Clinical trial
Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
NCT00227266 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00227266 |
|---|---|
| Title | Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy |
| Official title | Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial) |
| Lead sponsor | University of Utah, Other |
| Collaborators | Families of Spinal Muscular Atrophy Leadiant Biosciences, Inc. Industry Abbott |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Muscular Atrophy |
| Intervention type | Drug |
| Interventions | Valproic Acid and Levocarnitine, Placebo |
| Enrollment | 94 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 27, 2005 |
| Last update posted | Mar 19, 2025 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: